Alignment Healthcare, Inc. Common Stock (ALHC) is a publicly traded Healthcare sector company. As of May 21, 2026, ALHC trades at $16.58 with a market cap of $3.37B and a P/E ratio of 0.00. ALHC moved +1.80% today. Year to date, ALHC is -20.67%; over the trailing twelve months it is +6.25%. Its 52-week range spans $9.15 to $23.87. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces ALHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alignment Health Plan Earns 2026 Excellence Award, In Top 1.6% of MAPD Plans: Alignment Health Plan’s Medicare Advantage prescription drug plan secured the 2026 Excellence in Quality Award, earning a perfect 5-star rating on all five PQA medication measures and a 4.5-star Part D summary rating. The plan was one of only four MAPDs recognized—just 1.6% of the 613 eligible contracts.
| Metric | Value |
|---|---|
| Price | $16.58 |
| Market Cap | $3.37B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.87 |
| 52-Week Low | $9.15 |
| Volume | 560 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.95B |
| Net Income | $-978.00K |
| Gross Margin | 0.00% |
9 analysts cover ALHC: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.